ABX-CRO
The Leading CRO for development
of molecular imaging and radiotherapy agents
Critical for the successful and fast development of MRT assets is a powerful and >> Experienced Expert Team of Developers. Given the unexpected and still rising interest in the emergent radiopharmaceutical industry with many new companies, a fierce competition for staff experienced in radiopharmaceutical development has emerged. In fact, >> lack of qualified staff is one of the main reasons for >> delays or failure of radiopharma start-ups.
Through a >> Strategic Preferred Provider Alliance with ABX-CRO, the globally leading contract research organisation for radiopharmaceuticals, IODAX benefits from its inception from a >> Pre-formed Full Scale Expert Team, covering all aspects of radiopharmaceutical development, >> Saving IODAX time and money.
